1. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (22nd February 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pruritus Intensity Scales across Europe: a prospective validation study. (3rd February 2021) Authors: Storck, M.; Sandmann, S.; Bruland, P.; Pereira, M.P.; Steinke, S.; Riepe, C.; Soto‐Rey, I.; Garcovich, S.; Augustin, M.; Blome, C.; Bobko, S.; Legat, F.J.; Potekaev, N.; Lvov, A.; Misery, L.; Weger, W.; Reich, A.; Şavk, E.; Streit, M.; Serra‐Baldrich, E. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 5(2021) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Facets of shame are differently expressed in dermatological disease: a prospective observational study. (26th February 2020) Authors: Aberer, E.; Hiebler‐Ragger, M.; Zenker, M.; Weger, W.; Hofer, A.; Unterrainer, H.F. Journal: British journal of dermatology Issue: Volume 183:Number 1(2020) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Facets of shame are differently expressed in dermatological disease: a prospective observational study. (1st July 2020) Authors: Aberer, E.; Hiebler‐Ragger, M.; Zenker, M.; Weger, W.; Hofer, A.; Unterrainer, H.F. Journal: British journal of dermatology Issue: Volume 183:Number 1(2020) Page Start: 169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis*. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Biologic drug survival rates in the era of anti‐interleukin‐17 antibodies: a time‐period‐adjusted registry analysis. (1st June 2021) Authors: Graier, T.; Salmhofer, W.; Jonak, C.; Weger, W.; Kölli, C.; Gruber, B.; Sator, P.G.; Prillinger, K.; Mlynek, A.; Schütz‐Bergmayr, M.; Richter, L.; Ratzinger, G.; Painsi, C.; Selhofer, S.; Häring, N.; Wippel‐Slupetzky, K.; Skvara, H.; Trattner, H.; Tanew, A.; Inzinger, M. Journal: British journal of dermatology Issue: Volume 184:Number 6(2021) Page Start: 1094 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (1st October 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (5th August 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Cross‐European validation of the ItchyQoL in pruritic dermatoses. (25th September 2018) Authors: Zeidler, C.; Steinke, S.; Riepe, C.; Bruland, P.; Soto‐Rey, I.; Storck, M.; Garcovich, S.; Blome, C.; Bobko, S.; Legat, F.J.; Potekaev, N.; Lvov, A.; Misery, L.; Weger, W.; Reich, A.; Şavk, E.; Streit, M.; Serra‐Baldrich, E.; Szepietowski, J.C.; Yosipovitch, G. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 33:Number 2(2019) Page Start: 391 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Short‐ to intermediate‐term follow‐up in patients treated with the combination of 311‐nm ultraviolet B phototherapy and biological agents. (5th August 2014) Authors: Inzinger, M.; Legat, F.J.; Hofer, A.; Weger, W.; Gruber‐Wackernagel, A.; Salmhofer, W.; Wolf, P. Journal: British journal of dermatology Issue: Volume 171:Number 4(2014:Oct.) Page Start: 915 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗